ÂÜÀòÂÒÂ×

Dr. Bruce M. Halpryn is the Cofounder, Chief Executive Officer, and President of Eikonoklastes Therapeutics, Inc., leading the development of innovative therapies for inadequately treated diseases since March 2019. Halpryn holds significant leadership roles in various organizations, including chairing committees for Miami City Ballet and serving on the board of directors for FotoFocus Cincinnati and Cincinnati Ballet. Previous experience includes Chief Operating Officer at Myonexus Therapeutics, where gene therapies for Limb-girdle muscular dystrophy were developed, and Kinnear Pharmaceuticals, focusing on immune modulators. Additionally, Halpryn contributed as a Senior Advisor at Larta Institute and held senior positions at P&G Global Health Care, emphasizing innovation and technology development within the healthcare sector.